Cargando…
Using reported pathogenic variants to identify therapeutic opportunities for genetic diseases
PURPOSE: Drug development strategies for genetic diseases depend critically on accurate knowledge of how pathogenic variants cause disease. For some well‐studied genes, the direct effects of pathogenic variants are well documented as loss‐of‐function, gain‐of‐function or hypermorphic, or a combinati...
Autores principales: | Ressler, Andrew K., Goldstein, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834146/ https://www.ncbi.nlm.nih.gov/pubmed/36374045 http://dx.doi.org/10.1002/mgg3.2097 |
Ejemplares similares
-
Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities
por: Du, Xiaomi, et al.
Publicado: (2021) -
Pathogenic genetic variants identified in Australian families with paediatric cataract
por: Jones, Johanna L, et al.
Publicado: (2022) -
Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
por: Zhang, Ruxin, et al.
Publicado: (2023) -
Determining the Likelihood of Disease Pathogenicity Among Incidentally Identified Genetic Variants in Rare Dilated Cardiomyopathy‐Associated Genes
por: Yang, Qixin, et al.
Publicado: (2022) -
Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs
por: Al‐Shafai, Kholoud N., et al.
Publicado: (2021)